Pathways Picks July 27: Combo Product Policies, EU Updates, and More to Watch

article image

In this week’s roundup, China adds flexibility and clarifies combo product rules, and updates from the EU and Canada; the MDR regulatory rollout continues in Europe; India classifications; emergency use authorization transition bill, and more.

Combination product policy updates, including substantive reforms in China’s designation and submission process, lead off this week’s Pathways’ Picks, followed by EU regulatory news, and more from around the globe.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: